Prediction of Cognitive Decline in Parkinson’s Disease Using Clinical and DAT SPECT Imaging Features, and Hybrid Machine Learning Systems

Author:

Hosseinzadeh Mahdi12ORCID,Gorji Arman3,Fathi Jouzdani Ali3,Rezaeijo Seyed Masoud4ORCID,Rahmim Arman56,Salmanpour Mohammad R.15ORCID

Affiliation:

1. Technological Virtual Collaboration (TECVICO Corp.), Vancouver, BC V5E 3J7, Canada

2. Department of Electrical & Computer Engineering, University of Tarbiat Modares, Tehran 14115111, Iran

3. Neuroscience and Artificial Intelligence Research Group (NAIRG), Student Research Committee, Hamadan University of Medical Sciences, Hamadan 6517838736, Iran

4. Department of Medical Physics, Faculty of Medicine, Ahvaz Jundishapur University of Medical Sciences, Ahvaz 6135715794, Iran

5. Department of Integrative Oncology, BC Cancer Research Institute, Vancouver, BC V5Z 1L3, Canada

6. Departments of Radiology and Physics, University of British Columbia, Vancouver, BC V6T 1Z4, Canada

Abstract

Background: We aimed to predict Montreal Cognitive Assessment (MoCA) scores in Parkinson’s disease patients at year 4 using handcrafted radiomics (RF), deep (DF), and clinical (CF) features at year 0 (baseline) applied to hybrid machine learning systems (HMLSs). Methods: 297 patients were selected from the Parkinson’s Progressive Marker Initiative (PPMI) database. The standardized SERA radiomics software and a 3D encoder were employed to extract RFs and DFs from single-photon emission computed tomography (DAT-SPECT) images, respectively. The patients with MoCA scores over 26 were indicated as normal; otherwise, scores under 26 were indicated as abnormal. Moreover, we applied different combinations of feature sets to HMLSs, including the Analysis of Variance (ANOVA) feature selection, which was linked with eight classifiers, including Multi-Layer Perceptron (MLP), K-Neighbors Classifier (KNN), Extra Trees Classifier (ETC), and others. We employed 80% of the patients to select the best model in a 5-fold cross-validation process, and the remaining 20% were employed for hold-out testing. Results: For the sole usage of RFs and DFs, ANOVA and MLP resulted in averaged accuracies of 59 ± 3% and 65 ± 4% for 5-fold cross-validation, respectively, with hold-out testing accuracies of 59 ± 1% and 56 ± 2%, respectively. For sole CFs, a higher performance of 77 ± 8% for 5-fold cross-validation and a hold-out testing performance of 82 + 2% were obtained from ANOVA and ETC. RF+DF obtained a performance of 64 ± 7%, with a hold-out testing performance of 59 ± 2% through ANOVA and XGBC. Usage of CF+RF, CF+DF, and RF+DF+CF enabled the highest averaged accuracies of 78 ± 7%, 78 ± 9%, and 76 ± 8% for 5-fold cross-validation, and hold-out testing accuracies of 81 ± 2%, 82 ± 2%, and 83 ± 4%, respectively. Conclusions: We demonstrated that CFs vitally contribute to predictive performance, and combining them with appropriate imaging features and HMLSs can result in the best prediction performance.

Funder

Natural Sciences and Engineering Research Council of Canada

Publisher

MDPI AG

Subject

Clinical Biochemistry

Reference90 articles.

1. Cognitive Decline in Parkinson Disease;Aarsland;Nat. Rev. Neurol.,2017

2. Parkinson’s Disease: Clinical Features and Diagnosis;Jankovic;J. Neurol. Neurosurg. Psychiatry,2008

3. GBD 2016 Parkinson’s Disease Collaborators (2018). Global, Regional, and National Burden of Parkinson’s Disease, 1990–2016: A Systematic Analysis for the Global Burden of Disease Study 2016. Lancet Neurol., 17, 939–953.

4. Machine Learning Methods for Optimal Prediction of Motor Outcome in Parkinson’s Disease;Salmanpour;Phys. Med.,2020

5. Development and Validation of a Prognostic Model for Cognitive Impairment in Parkinson’s Disease With REM Sleep Behavior Disorder;Chen;Front. Aging Neurosci.,2021

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3